SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 406 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,590,489 | +37.2% | 54,368 | +29.6% | 0.02% | 0.0% |
Q2 2023 | $4,802,511 | -38.5% | 41,936 | -25.9% | 0.02% | -85.5% |
Q1 2023 | $7,805,175 | -6.6% | 56,629 | -12.2% | 0.12% | -23.0% |
Q4 2022 | $8,353,893 | +190.7% | 64,469 | +148.0% | 0.15% | +176.4% |
Q3 2022 | $2,874,000 | -31.1% | 26,000 | -51.3% | 0.06% | -50.5% |
Q1 2022 | $4,169,000 | +111.6% | 53,361 | +144.0% | 0.11% | +82.0% |
Q4 2021 | $1,970,000 | +401.3% | 21,873 | +415.0% | 0.06% | +454.5% |
Q3 2021 | $393,000 | -53.3% | 4,247 | -62.4% | 0.01% | -77.6% |
Q1 2021 | $841,000 | -77.1% | 11,282 | -60.4% | 0.05% | -79.4% |
Q4 2019 | $3,678,000 | +232.2% | 28,500 | +93.9% | 0.24% | +260.6% |
Q3 2019 | $1,107,000 | -34.4% | 14,700 | +32.3% | 0.07% | -64.3% |
Q2 2019 | $1,688,000 | – | 11,111 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |